Evidence map›Paper›PMID 42261782›Full record

ArticleActa paediatrica (Oslo, Norway : 1992)2026

Sepsis and Antibiotics in Extremely Preterm Infants: Early Empirical Treatment Was Common, While Late-Onset Sepsis Accounted for Most Cases and Antibiotic Use.

Anna Bjerager Arnesen, Nini Møller, Louise Dyrberg Vibede, Kristian Vestergaard, Sara Krøis Holm, Cæcilie Trier, Hristo Stanchev, Gholamreza Dayani, Ulrikka Nygaard, Bo Mølholm Hansen and 1 more

Abstract read
In one paragraph

Article in Acta paediatrica (Oslo, Norway : 1992), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Anna Bjerager ArnesenDepartment of Neonatology, Copenhagen University, Copenhagen, Denmark.ORCID https://orcid.org/0009-0008-7782-3589
Nini MøllerDepartment of Gynaecology and Obstetrics, Copenhagen University, Hillerød, Denmark.
Louise Dyrberg VibedeDepartment of Paediatrics and Adolescent Medicine, Copenhagen University, Herlev, Denmark.
Kristian VestergaardDepartment of Paediatrics and Adolescent Medicine, Copenhagen University, Holbæk, Denmark.
Sara Krøis HolmDepartment of Neonatology, Copenhagen University, Copenhagen, Denmark.
Cæcilie TrierDepartment of Paediatrics and Adolescent Medicine, Copenhagen University, Nykøbing-Falster, Denmark.ORCID https://orcid.org/0000-0001-5935-0863
Hristo StanchevDepartment of Paediatrics and Adolescent Medicine, Copenhagen University, Slagelse, Denmark.
Gholamreza DayaniDepartment of Paediatrics and Adolescent Medicine, Copenhagen University, Roskilde, Denmark.
Ulrikka NygaardDepartment of Paediatrics, Copenhagen University, Copenhagen, Denmark.
Bo Mølholm HansenDepartment of Paediatrics and Adolescent Medicine, Copenhagen University, Hillerød, Denmark.ORCID https://orcid.org/0000-0002-3087-3983
Emma Malchau CarlsenDepartment of Neonatology, Copenhagen University, Copenhagen, Denmark.

Funding

Innovationsfonden 0176-00020B
6 · The paper itself

Abstract

aimThe aim was to investigate the incidence of sepsis and use of antibiotics among extremely preterm infants, given the limited number of population-based studies examining this.

methodsThis retrospective study in Eastern Denmark included all liveborn infants from 23 + 0 weeks/days to 27 + 6 weeks/days of gestation from 2019 to 21. Data on dispensed intravenous antibiotics were obtained from the regional joint electronic health platform. Early-onset sepsis was defined as occurring within the first 72 h of life and late-onset sepsis from 3 to 90 days. Positive blood culture episodes were classified as proven sepsis.

resultsWithin the first six months of life, 187 of the 232 (81%) infants received intravenous antibiotics. Empirical treatment was initiated for early-onset sepsis in 164 of the 232 infants (71%) and late-onset sepsis in 118 (51%). Late-onset sepsis accounted for 90% of proven sepsis, predominantly caused by Staphylococcus aureus and Coagulase-negative Staphylococcus. Antibiotic use for late-onset sepsis was three-fold higher than for early-onset sepsis (9902 versus 3413 days per 1000 live births). Sepsis caused two deaths (9 per 1000 live births infants).

conclusionSuspected early-onset sepsis was the most common indication for antibiotic initiation, but late-onset accounted for most proven sepsis episodes and antibiotic exposure in extremely preterm infants.

Indexed as

Anti-Bacterial AgentsInfant, Premature, DiseasesNeonatal SepsisSepsisDenmarkFemaleHumansIncidenceInfant, Extremely PrematureInfant, NewbornMaleRetrospective StudiesAnti-Bacterial Agentsblood stream infectionsearly empirical treatmentextremely preterm infantslate‐onset sepsisneonatal infections

Identifiers

PMID42261782
PMCPMC13552603

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.